Prescient Therapeutics Limited

Prescient Therapeutics Limitedverified

PTX.AX

Price:

$0.048

Market Cap:

$38.66M

Prescient Therapeutics Limited, a clinical stage oncology company, develops novel drugs for the treatment of various cancers in Australia. Its lead drug candidate is PTX-200, which is in Phase 2a clinical trial for HER2-negative breast cancer, Phase IB/2 clinical trial in relapsed and refractory AML, and Phase 1b in recurrent or persistent platinum-resistant ovarian cancer; and PTX-100, a RhoA inhibitor, for hematological and solid malignancies that focuses on cancers with Ras and RhoA mutations. It has a strategic collaboration with The University of Texas MD Anderson Cancer Center to develop blood cancer binder for OmniCAR. The company was formerly known as Virax Holdings Limited and chang...[Read more]

Industry

Biotechnology

IPO Date

1999-01-03

Stock Exchange

ASX

Ticker

PTX.AX

The Enterprise Value as of January 2025 (TTM) for Prescient Therapeutics Limited (PTX.AX) is 28.49M

According to Prescient Therapeutics Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 28.49M. This represents a change of -40.84% compared to the average of 48.16M of the last 4 quarters.

Prescient Therapeutics Limited (PTX.AX) Historical Enterprise Value (quarterly & annually)

How has PTX.AX Enterprise Value performed in the past?

The mean historical Enterprise Value of Prescient Therapeutics Limited over the last ten years is 33.20M. The current 28.49M Enterprise Value has changed 8.48% with respect to the historical average. Over the past ten years (40 quarters), PTX.AX's Enterprise Value was at its highest in in the June 2021 quarter at 141.13M. The Enterprise Value was at its lowest in in the June 2016 quarter at -1038730.69.

Quarterly (TTM)
Annual

Average

33.20M

Median

16.02M

Minimum

-2611426.04

Maximum

133.96M

Prescient Therapeutics Limited (PTX.AX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Prescient Therapeutics Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 850.76%

Maximum Annual Enterprise Value = 133.96M

Minimum Annual Increase = -13864.61%

Minimum Annual Enterprise Value = -2611426.04

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202422.05M-58.42%
202353.03M-39.83%
202288.15M-34.20%
2021133.96M850.76%
202014.09M-13864.61%
2019-102363.09-100.57%
201817.95M438.48%
20173.33M-227.66%
2016-2611426.04-221.65%
20152.15M-356.84%

Prescient Therapeutics Limited (PTX.AX) Average Enterprise Value

How has PTX.AX Enterprise Value performed in the past?

The current Enterprise Value of Prescient Therapeutics Limited (PTX.AX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

54.41M

5-year avg

62.26M

10-year avg

33.20M

Prescient Therapeutics Limited (PTX.AX) Enterprise Value vs. Peers

How is PTX.AX’s Enterprise Value compared to its peers?

Prescient Therapeutics Limited’s Enterprise Value is less than Imugene Limited (228.29M), less than Actinogen Medical Limited (69.19M), greater than Patrys Limited (3.93M), less than Antisense Therapeutics Limited (0), less than Immutep Limited (350.88M),

Build a custom stock screener for Prescient Therapeutics Limited (PTX.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Prescient Therapeutics Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Prescient Therapeutics Limited (PTX.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Prescient Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Prescient Therapeutics Limited's Enterprise Value?

What is the highest Enterprise Value for Prescient Therapeutics Limited (PTX.AX)?

What is the 3-year average Enterprise Value for Prescient Therapeutics Limited (PTX.AX)?

What is the 5-year average Enterprise Value for Prescient Therapeutics Limited (PTX.AX)?

How does the current Enterprise Value for Prescient Therapeutics Limited (PTX.AX) compare to its historical average?